14-day Premium Trial Subscription Try For FreeTry Free
DLA Piper represented advised NuVasive, Inc. (NASDAQ: NUVA), a San Diego-based medical device company that creates and distributes products for surgical treatment of spine disorders, in its offering o
The Global Spinal implants Market will grow by $2.75 bn during 2020-2024.
NuVasive, Inc. (NASDAQ: NUVA) announced today that it closed the issuance of an additional $50.0 million in aggregate principal amount of the 1.00% Convertible Senior Notes due 2023 (the "Convertible
Jun 02, 2020 (Market Insight Reports) -- A recent report on Spinal Fusion Devices Market provides a detailed analysis of the industry size, revenue forecasts...
Jun 02, 2020 (Heraldkeepers) -- New York, June 2, 2020:You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports...
NuVasive, Inc. (NASDAQ: NUVA) announced today the pricing of its offering (the "Offering") of $400.0 million aggregate principal amount of 1.00% Convertible Senior Notes due 2023 (the "Convertible Not
AGF Investments Inc. bought a new stake in shares of NuVasive, Inc. (NASDAQ:NUVA) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought
NuVasive, Inc. (NASDAQ: NUVA) announced today that it intends to offer (the "Offering"), subject to market and other considerations, $400.0 million aggregate principal amount of Convertible Senior Not
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its LessRa
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that manag
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE